#Bayer just announced a massive partnership with #Kumquat Biosciences Inc. worth up to $ 1.3 billion to tackle one of #cancer's most challenging targets: #KRAS #G12D mutations.
• KRAS mutations drive nearly 25% of all human cancers
• G12D has NO effective treatments
www.bayer.com/en/us/news-s...
1
0
0
0
